HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $403,000 | +32.6% | 26,000 | +67.7% | 0.07% | +231.8% |
Q1 2018 | $304,000 | -65.7% | 15,500 | -77.3% | 0.02% | -26.7% |
Q1 2017 | $886,000 | +14.0% | 68,400 | +6.4% | 0.03% | -86.0% |
Q3 2016 | $777,000 | +447.2% | 64,300 | +328.7% | 0.21% | +250.8% |
Q1 2016 | $142,000 | -35.7% | 15,000 | -8.9% | 0.06% | -1.6% |
Q3 2015 | $221,000 | +87.3% | 16,472 | +35.0% | 0.06% | +59.0% |
Q4 2014 | $118,000 | -13.9% | 12,200 | -12.2% | 0.04% | -39.1% |
Q2 2014 | $137,000 | -63.0% | 13,900 | -58.5% | 0.06% | -8.6% |
Q3 2013 | $370,000 | – | 33,500 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |